PrintThe Burrill Report
The Burrill Report (November 7, 2011): What 7 Billion people and a Graying Population Mean for Healthcare (.MP3,10.13 Mb)
The world hit a milestone earlier this month as the total number of people now living on planet Earth reached 7 billion. At the same time, Baby Boomers this year began crossing the threshold of retirement age. We spoke to David Foot, professor of economics at the University of Toronto, about these demographic trends, what they mean for healthcare, and whether policymakers and drugmakers are paying enough attention to these trends to plan for the future. Please note there are brief moments during this interview where technical difficulties during this interview caused us to lose brief moments.
November 04, 2011
http://www.burrillreport.com/article-what_a_growing_and_aging_world_mean_for_healthcare_.html
GLOBAL HEALTH
What a Growing and Aging World Mean for Healthcare
Podcast: November 7, 2011[Please login to post comments]
- Biggest Market Movers
Read More - Pfizer's and Teva's Results Point to Shifting Demand
Read More - Payment Disclosure Rules Still Unclear
Senators, companies criticize lack of direction on reporting potential conflicts. Read More - Seeking to End Drug Shortages
Obama orders FDA and DOJ to act to reduce shortages of critical medicines. Read More - Encouraging Data Sends Medivation Soaring
Late-stage interim results for experimental prostate cancer drug promising, cast cloud over competitors. Read More - Mayo Researchers Look to Exploit Measles to Treat Cancer
Modified virus may offer a less toxic alternative to chemotherapy and radiation. Read More - Sanofi Set to Pass Pfizer as Biggest Drug Company
Pfizer will fall to third place behind Novartis as best seller Lipitor loses patent protection. Read More - Proposed Indian Pricing Scheme Could Slash Prices on Foreign Drugs
Drugmakers ready to oppose policy that some say could cut prices by as much as 90 percent. Read More - GSK Reaches $3 Billion Settlement with U.S. over Criminal and Civil Investigations
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More - A Novel Approach to Funding a Startup
Versant Ventures builds in a potential exit for its Quanticel investment by teaming up with Celgene Read More
.gif)
